Skip to main content
Investors
Scibase.com
Open menu
At a Glance
Open link menu
At a Glance
Investment Case
Our Strategy
Market Overview
Results & Reports
Open link menu
Results & Reports
Calendar
Financial Data
The Share
Open link menu
The Share
Shareholders
Insider Transactions
Analysts
Prospectus Regarding Shares
Share Capital Development
Warrants
Governance
Open link menu
Governance
Management and Board of Directors
Annual General Meeting
Articles of Association
Auditor
Certified Advisor
Committees
ESG - sustainability
Releases
Open link menu
Releases
Subscription Service
EN
Current language English, click to switch language
SV
Switch to Svenska
Search
Search
Search
Search on a site
Please fill out this field
Back
Close menu
Search on a site
Please fill out this field
Close
Jun 17 2025
Bulletin from the annual general meeting in SciBase Holding AB (publ)
Jun 16 2025
SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million
Jun 16 2025
SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30
Jun 09 2025
SciBase Initiates Self-Pay Model in the US to Make Nevisense Test More Accessible to Patients
Jun 04 2025
SciBase Expands Further Through European Market with First Sales Order to customer in Italy
May 27 2025
SciBase reaches milestone with over 300,000 patients tested with Nevisense
May 14 2025
Notice to attend the annual general meeting in Scibase Holding AB (publ)
Interim report
May 13 2025
Interim report
Apr 11 2025
SciBase launches next generation Nevisense
Pagination
First page
Previous page
Page
1
Current page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Last page
Subscribe to
Close popup
Left
Right
